LIMSource News: What's New: September to October 2007

• Sapio Sciences to Host Free Webcast on LIMS for Genotyping & Gene Expression Labs
• ATL to Host Free LIMS Seminar
• Thermo Fisher Scientific Selected by China Doping Control Center to Supply Sports Doping Testing Instrumentation at the 2008 Beijing Olympics
• ABR Implements Green Mountain Logic's LabPas CT LIMS for Phase 1 Clinical Trials
• Thermo Fisher Scientific Incorporates Data Manager into Nautilus LIMS 8.0 to Deliver Complete Data Storage and Retrieval System
• Autoscribe Releases New Software to Manage, Track and Consign Hazardous Waste
• Global Manufacturer of Motion and Control Technologies Licenses LabVantage’s Sapphire to Enhance Laboratory Management Workflow
• Croatian PHI of Sibensko-Kninska county Licensed Pardus' eQMS::LIMS
• Vanderbilt University’s Jim Ayers Institute Installs Genologics' Proteus to Manage Cancer Research Data
• QSI Introduces New RisQ Software Package
• Thermo Fisher Scientific Launches Enhanced Informatics Partner Program Extending the benefits and reach of Laboratory Informatics
• LabPas CT Selected by Qualia Clinical Services for Phase I Clinical Trials
• Bruker Daltonics Introduces New Novel Proteomics Capabilities and Solutions
• Thermo Fisher Scientific Announces New Software Control for the Accela High Speed LC System Using Atlas CDS
• Thomson Acquires Bioinformatics Company
• National Instruments Extends LabVIEW Embedded Platform to Support New Analog Devices Blackfin, Freescale ColdFire Processors
• Invetech Expands its Service Offering into the Drug Discovery Market
• Thermo Fisher Scientific Works with Microsoft to Web-Enable its LIMS Solutions
• Labtronics Partners with PEC & Technologies for Distribution of LimsLink to Forensic Laboratories
• ClinPhone Announces Significant New Contract with Bayer Yakuhin Ltd, Japan
• Multinational Biopharmaceutical Company Licenses LabVantage's Sapphire to Support Its Core Biomaterial Research for Cancer and Immunological Therapies
• National Instruments Introduces LabVIEW 8.5 Real-Time
• ARTEL Extreme Pipetting Expedition to Visit Death Valley to Test Impact of Dry Heat on Laboratory Data
• Labtronics Releases LimsLink v4.1
• Shell Global Solutions Utilizes Thermo Fisher Scientific iCAP 6500 Spectrometer for Testing Racing Cars at Le Mans 2007
• PerkinElmer Introduces New Gas Chromatograph
• Conner Announces Plan to Improve Quality Compliance of Genetically Engineered Products
• Thermo Fisher Scientific Appointed as Corporate Standard LIMS Supplier for South African Utilities Organization
• QSI Establishes New Division in France
• Spellex Releases Spellex Biotech V.2007, the Newest Upgrade of the World’s First Bioscience Spell Checking Software
• Virginia Bioinformatics Institute Implements Metabolomics Software from ACD/Labs to Tackle Biomedical and Agricultural Research
• Labtronics' NAP Version 4.4 Released with New Enhancements for Significant Timesavings
• STARLIMS to be Implemented by Schiff Nutrition International
• QSI and Brady Corporation Link the Sample to the Data
• ClinPhone and LabPas CT Agree to Interface
• Spellex Releases Spellex Biotech v.2007 Bioscience Spell Checking Software
• ALA Expands Innovation AveNEW Program Globally Partnering with BioAlps Switzerland
• Bruker BioSciences Reports Strong Revenue and Net Income Growth in the Second Quarter of 2007
• STARLIMS Receives ‘Designed for EMC Documentum’ Accreditation
• Leading Nutritional Supplement Manufacturer Selects STARLIMS
• etrials EDC to Interface with Green Mountain Logic's LabPas CT LIMS
• ChemSW Releases New Industry White Paper on How to Survive a Chemical Management Audit

Sapio Sciences Releases Copy Number Variation (CNV) Analysis Tool For Illumina Infinium Arrays

Sapio Sciences has announced Exemplar Analytics 4.0.8, the first commercial solution, outside of Illumina, to provide CNV analysis for the Illumina family of arrays. Copy number variation analysis is a powerful and widely used method for identifying insertions and deletions in the genome. The identification of these chromosomal alterations is critical in understanding cancer as well as other serious diseases. This release of Exemplar Analytics also includes the following new features: Full support of all Illumina DNA Analysis BeadChips from the Human-1 to Human1M BeadChip; Principal Component Analysis for admixture corrections; Proper Allele counting of Hemizygous SNP’s; Complete update of the annotations database with current information from dBSNP, Entrez Gene and Gene Ontology; and, Multi-Processor support for permutation corrections on statistics.
Full Support of Copy Number analysis for the Affymetrix 10K-500K, 5.0 and 6.0 arrays. "We have seen significant demand for an Illumina copy number variation analysis program from both our customers and prospects. With this release we now offer a comprehensive copy number variation solution for the researchers using either Illumina or Affymetrix arrays. We believe this valuable tool will further researchers understanding of the most serious diseases afflicting humans.” According to Kevin Cramer, CEO at Sapio, “When you combine this with our built in annotations database, 80 additional statistics in support of Genome-Wide Association Studies, Quantitative Trait Analysis and Family based studies, Exemplar Analytics is a one stop
solution for researchers undertaking genetics based studies.” For details, visit http://www.sapiosciences.com.

Bruker Companies Announce the Opening of a Modern Chinese Applications, Demonstration and Customer Training Center in Beijing

During the BCEIA 2007 conference, Bruker BioSciences Corp. and the Bruker BioSpin group of companies have announced the official opening of their new Beijing modern applications, demonstration and customer training laboratory, showcasing a wide selection of novel life science and materials research, as well as industrial analysis systems. The new demonstration and training facility includes sample preparation areas and laboratory space equipped with the very latest systems from each of the Bruker companies. Clive Seymour, Bruker Daltonics Vice President for Asia-Pacific, commented: "Our new and expanded demonstration facility provides the opportunity for scientists to investigate a wide range of applications on our innovative systems, together with obtaining training, demonstrations and advice from Bruker's highly qualified and experienced Beijing team of application scientists. We will provide workshops and training courses here to ensure that our customers gain the maximum benefit from their Bruker products and solutions." The new Bruker combined Beijing Demonstration Centre is located at 11 Zhong Guan Cun, South Avenue, Beijing. For details, visit http://www.bruker.com.cn.

QATrax Releases Management Reports Solution for Test Labs

QATrax has released Management Reports v1.1, which ships October 2007. This product has been in use for several years. The new version is based on Microsoft's .NET. The reports are faster and simpler to use.
Significant enhancements to the Management Reports module provide Users with a flexible tool to access information. Users can selectively grab information and export to Excel and other formats. QATrax is evolving to easily handle Dynamic Scheduling in Active Environments. Auto-Scheduling provides a significant edge in the dynamic and complex product development world. QATrax will help minimize the disruptions and time spent in accommodating schedule changes and the downstream “ripples” they cause. With test labs spread around the globe, your goal is to manage the entire process. Our goal is to simplify the task. To provide visibility and process, TraxStar envisions a Global Test Lab Network linking labs inside the firewall while providing access to and by other constituencies; industry groups, independent test labs and customers. For details, visit http://www.traxstar.com.

PerkinElmer Introduces Series 200EP Photo Diode Array Detector

PerkinElmer has introduced a new Photo Diode Array (PDA) detector to expand the capabilities of their Series 200 HPLC offering – the Series 200EP (Enhanced Performance) PDA. The new detector provides deeper insights into results through superior linearity and best-in-class spectral integrity, allowing uncompromised quali-quantitative analysis of complex mixtures. With its wide linear dynamic range and low drift, the Series 200EP PDA detector is the ideal tool for demanding quantitative analyses like impurities in drug or environmental samples with wide variation in compound concentration. Coupled with TotalChrom Chromatography Data Systems, the Series 200EP PDA detector is fully network compatible. In addition, IRIS® Spectral Processing Software provides intuitive spectral data processing, all protected under a fully 21 CFR Part 11-compliant architecture. For details, visit http://www.perkinelmer.com/Series200EPPDA.

Sapio Sciences to Host Free Webcast on LIMS for Genotyping & Gene Expression Labs

Sapio Sciences will be hosting a free webcast entitled LIMS for Genotyping & Gene Expression Labson November 7 at 1:30p.m. EST. Advances in Genotyping and Gene Expression technologies, primarily from Illumina and Affymetrix, have presented new challenges to Lab Managers. Managing samples, tracking complex lab protocols and the storage & management of the immense amounts of data being produced requires an integrated solution designed to address these key areas. Topics to be covered in the webcast include: Sample Management & Tracking; Plate Management; Protocol Tracking for Affymetrix & Illumina Experiments; FDA\GLP\GCP Compliance; Storing\Managing SNP and Gene Expression Data with Samples; Instrument Integration; Customizing and Extending the LIMS; and, Analytics Annotations and Graphics. For details and to register, visit http://www.sapiosciences.com.

ATL to Host Free LIMS Seminar

Accelerated Technology Laboratories, Inc. (ATL) is hosting a free, educational breakfast seminar at the Hilton (Dunn Conference Room) in Charlotte, NC on November 5 from 7:15-8:15 am. The seminar, entitled Why a Laboratory Information Management System (LIMS) is the Key to Streamlining Water /Wastewater Laboratory Operations and Staying Compliant, will focus on why a Laboratory Information Management System (LIMS) is the key to streamlining water and wastewater laboratory operations and staying compliant. This event will take place before the 2007 AWWA Water Quality Technology Conference and Exposition (WQTC) begins on Monday, November 5th in Charlotte, North Carolina. Featured speakers include John Keith, Manager of Laboratory Services at Lincoln Water System and Dr. Christine Paszko, Vice President of Sales and Marketing at ATL. Seminar topics include: "Utilizing a LIMS to Increase Efficiency in a Water Quality Laboratory" and “Advantages of a COTS (Commercial-off-the-Shelf) LIMS for Water Quality Laboratories.” To register for the seminar email Ken Ochi at kochi@atlab.com or visit http://www.atlab.com/events.

Thermo Fisher Scientific Selected by China Doping Control Center to Supply Sports Doping Testing Instrumentation at the 2008 Beijing Olympics

Thermo Fisher Scientific Inc., the world leader in serving science, has announced that the China Doping Control
Center (CDCC) has selected Thermo Scientific instruments and software for its sports testing program at the 29th Olympic Games in Beijing. The CDCC has been accredited by the Chinese government and the International Olympic Committee (IOC) to conduct all doping control analyses during the 2008 Olympic Games. Identifying illegal performance-enhancing substances that are used in sports competition is a growing global challenge, one made more difficult by the development of ever more sophisticated drugs that are increasingly difficult to detect. The analytical systems Thermo Fisher supplied to CDCC are ideally suited for this challenge, providing the high specificity, low limits of detection, high throughput and reliability required in today's sports testing environment. Thermo Fisher provided the CDCC with a range of high precision and performance Thermo Scientific instrumentation, including two DFS Sector Field GC/MS systems, a DELTA V isotope ratio mass spectrometer and four triple-quadrupole TSQ Quantum Access LC/MS systems. These instruments and associated software will enable the CDCC to cope with the high volume of samples expected at the 2008 Olympic Games. Thermo Fisher has also agreed to provide 24/7 technical and application assistance to the CDCC to ensure uninterrupted operation and successful, secure handing of athlete samples throughout the games. The CDCC sports doping testing program will start even before the opening of the competition, and continue from athletes' check-in at the Olympic Village until the end of the Games. All samples will be analyzed strictly in accordance with the IOC anti-doping rules for banned substances. With many thousands of samples to run and a long list of banned substances to potentially identify, the CDCC placed a high priority on acquiring automated systems that provide high accuracy, sensitivity and throughput. For details, visit http://www.thermo.com.

ABR Implements Green Mountain Logic's LabPas CT LIMS for Phase 1 Clinical Trials

Advanced Biomedical Research, Inc. (ABR), an international, full-service CRO, has announced that LabPas CT is live in their production environment and will be used to automate the conduct of their Phase I trials in their 72-bed research unit. "ABR is committed to employing the latest information technology to perform, manage and monitor clinical trials in a cost-efficient and rapid manner,” said Dr. Michael Willett, President and CEO of ABR. “The adoption of LabPas CT has gone remarkably smoothly thanks to the combination of outstanding support from the LabPas staff and the efforts and incredible enthusiasm of our own clinical staff.” ABR is a full-service, Phase I-IV global CRO dedicated to meeting the needs of pharmaceutical, biotechnology, and medical device companies. ABR offers an extensive range of clinical services including clinical study design, strategic and regulatory consulting, project management, monitoring, clinical data management, biostatistics, pharmacokinetic and pharmacodynamic analysis, quality assurance auditing, medical writing, pharmacovigilance and regulatory submissions. ABR has tested numerous innovator and generic compounds in its state-of-the-art Phase I-II clinical research facilities in New Jersey and performs a wide range of clinical trials including first-in-human, dose escalation, proof of concept, bioavailability, bioequivalence, PK/PD, fed-fasted, drug-drug and drug-alcohol interactions and thorough or definitive QTc evaluations. ABR has also recently expanded its portfolio of services to include bioanalytical, formulation development, organic synthesis and clinical supplies release and stability testing through it’s partner, Frontage Laboratories. For details, visit http://www.abr-pharma.com or http://www.gmlogic.com.

Thermo Fisher Scientific Incorporates Data Manager into Nautilus LIMS 8.0 to Deliver Complete Data Storage and Retrieval System

Thermo Fisher Scientific Inc. has incorporated award-winning data management functionality into its Nautilus LIMS version 8.0. Now installed with Data Manager, Thermo Scientific Nautilus can capture, archive and store both derived and raw instrument data, permitting users instant access and manipulation of the data without the original software. Data Manager is a complete storage and retrieval system that understands and preserves analytical data, documents and PDF (Portable Document Format) files. Designed to address long term storage issues by being platform and manufacturer independent, it is able to view, search and manipulate real data and its metadata without the original application. Thermo Scientific Nautilus 8.0 has been designed to give scientists a comprehensive instrument unified view of all relevant data directly from the LIMS rather than at the lab bench via multiple software packages. Drawing on technology from Thermo Scientific’s GRAMS Suite - a solution for visualizing, processing and managing spectroscopy data - the Data Manager module converts instrument data to a vendor neutral XML format and allows automatic linking to LIMS entities for instant investigation of suspect results. Using a converter library of over 150 file formats, instrument data can be translated into a platform-neutral XML (eXtensible Mark-up Language) that enables it to be retrieved and visualized on virtually any platform, with no reliance on the original instrument software. In binding these converted XML files to LIMS entities, Nautilus 8.0 with Data Manager is unique in providing an organization with the ability to share, compare, query and visualize analytical data, with or without the original instrument hardware/software. Nautilus 8.0 with Data Manager’s standards-based approach promotes knowledge-sharing through secure, company-wide access to information. This is especially important in today’s merger bound organizations that need to rationalize and retire instrument systems while retaining usable long-term access to valuable raw data. This advanced data management functionality is available as standard upon installation or upgrade to Nautilus LIMS version 8.0. Customers only need to purchase the appropriate converter library for their instrumentation to utilize the extra power of vendor neutral data storage. For details,visit http://www.thermo.com/informatics.

Autoscribe Releases New Software to Manage, Track and Consign Hazardous Waste

Autoscribe has released Matrix Hazardous Waste Tracker, a Microsoft Windows based system designed to track, locate and consign any type of hazardous waste samples anywhere in an organisation for compliance with regulatory authority legislation. This barcode ready tracking system allows the registration of hazardous waste items, progress/status checking, chain of custody management and reporting, lookup of EWC lists and consignment of hazardous waste. Details of carriers, consignees and users, with their associated authority, are all stored within the system. Matrix Hazardous Waste Tracker simplifies hazardous waste management by tracking work and samples to comply with EU / EWC / Environment Agency regulations. Matrix Hazardous Waste Tracker enhances traceability and accountability by auditing all actions and eliminates errors by allocating a unique identifier to each item of hazardous waste. Immediate feedback on waste status using the status features. The system is delivered with fully configurable reports which include waste status on-site and waste status consigned off-site for specified date ranges. All systems are fully configurable and may be configured via Autoscribe’s unique OneTime Configuration tools for use over the LAN, WAN or Web. Systems may be easily upgraded to full LIMS / Business System Management functionality. For details, visit http://www.autoscribe.co.uk.

Global Manufacturer of Motion and Control Technologies Licenses LabVantage’s Sapphire to Enhance Laboratory Management Workflow

LabVantage has announced that its Sapphire LIMS has been licensed by one of the world's leading diversified manufacturers of motion and control technologies. The core division utilizing Sapphire LIMS has operations around the world and focuses on manufacturing and testing of diesel engine filters. This global manufacturer's quality assurance and control laboratories were seeking a solution that could deliver an automated workflow that mimicked the manual processes it had in place. By implementing Sapphire and its configurable workflow functionality, it can quickly automate its workflow to easily track samples, apply barcodes, and produce reports for all key areas of production and quality management. The ease-of-use, coupled with the zero-footprint of the Sapphire thin-client will enable this multibillion dollar global leader to efficiently roll our enterprise Sapphire solution out to its worldwide manufacturing facilities. This functionality, combined with the built-in automated workflow, and the ability to produce key reports, were some the primary drivers for its choice of the Sapphire solution. For details, visit http://www.labvantage.com.

Croatian PHI of Sibensko-Kninska county Licensed Pardus' eQMS::LIMS

The Croatian public health institute (PHI) will use Pardus' eQMS::LIMS in day-to-day activities of monitoring food, air, sea and water safety and quality. eQMS::LIMS will represent backbone of the whole laboratory workflow in health ecology department (monitoring quality and compliance of food, drinking water, sea, general merchandise and air) taking care of various stages during analytical process -- from taking samples, analyzing, collecting and storing data to delivery of final results and statistical reports. eQMS::LIMS is flexible, crossindustry LIMS that streamlines processes throughout an analytical, research or quality control laboratories. Pardus' LIMS unifies diverse sets of biological, chemical or physical data collected across corresponding analytical laboratories into a unified central database. Assignments, data and job queues are presented through a browser based user interface, hence any personal computer equipped with Internet Explorer can readily access the system. Thanks to its architecture eQMS::LIMS functions and data can be accessed through various channels such as mobile phones thus offering platform for implementation of rapid alerting or critical control point monitoring applications in regulated environments. Pardus is a software development company providing its clients with turn-key ICT solutions based upon the best-of-the-breed technologies and best quality services. For details, visit http://www.pardus.hr.

Vanderbilt University’s Jim Ayers Institute Installs Genologics' Proteus to Manage Cancer Research Data

GenoLogics, a leading developer of lab and data management software solutions for life sciences research, has announced Vanderbilt University’s Jim Ayers Institute for Precancer Detection and Diagnosis has implemented GenoLogics’ Proteus laboratory and data management solution. Proteus was selected to assist with the Ayers Institute research focused on early identification and treatment of colorectal cancer. The Ayers Institute, led by Dr. Daniel Liebler, is working in conjunction with the Vanderbilt-Ingram Cancer Center and the Vanderbilt GI SPORE program towards the ultimate goals of developing a blood test for early detection of colorectal cancers, as well as individualized therapies or ‘personalized medicine’ for targeted treatment of specific tumor types. This ambitious research involves extensive clinical trials with thousands of participants at centers across the US, necessitating effective sample tracking and data storage. The Proteus data management solution gives researchers the ability to incorporate clinical data and track non-identifiable patient data, and its LabLink web collaboration system allows Vanderbilt University’s global network of collaborators to submit and receive sample information in Excel format. Proteus lets researchers create elaborate searches and perform data comparisons involving disease states and tissue proteotypes. Proteus’ powerful search functionality allows for quick and easy access to data and facilitating deep data mining. Samples that enter the Ayers Institute labs can be easily added with a mouse click and recorded using bar codes, which reduces errors from manual entry and decreases the time needed to log in samples. James DeGreef, VP Product Management at GenoLogics, commented, “Vanderbilt University is known as a true technology leader in the field of proteomics research and we are extremely pleased that they have chosen a GenoLogics lab and data management solution to aid them with their early detection cancer research. We have a collaborative relationship with the Jim Ayers Institute and we will work closely with them as they implement our solution." A proteomics LIMS that would improve laboratory efficiency and productivity was a key requirement for the Ayers Institute, because the more quickly research progresses, the sooner thousands of Americans who suffer from colorectal cancer (the second most common cancer in the US) may benefit from targeted therapies designed for the specific type and stage of their cancer. GenoLogics is proud to provide an effective tool to the Ayers Institute and the Vanderbilt-Ingram Cancer Center enabling them towards a future where cancers are either detected at the precancerous stage, or cured through personalized therapies. For details, visit http://www.vicc.org/jimayersinstitute or http://www.genologics.com.

QSI Introduces New RisQ Software Package

Accidental exposure to chemicals in the working environment can have serious consequences. Workers’ health can be ruined and the legal and financial outcomes can destroy businesses. Careful and detailed Risk Assessment is an essential step towards protecting employee and employer alike. The new RisQ software package from Quality Systems International (QSI) is a unique tool that takes all the hard work out of generating Risk Assessment documentation in any organisation where hazardous chemicals are handled. Health and Safety regulations require employers to generate and maintain detailed Risk Assessments to COSHH standards. This can be time consuming and laborious, involving searches of MSDS records, inventories and materials schedules, but failure to comply can result in heavy penalties in the event of an accident and subsequent HSE investigation. RisQ uses a simple Wizard-based approach to combine materials data and process information to create a detailed risk assessment based on Royal Society of Chemistry guidelines. MSDS data on all materials together with other required data, e.g. physical properties, are stored and updated within the application. RisQ also includes management screens for handling materials storage and deliveries. The Risk Assessment is generated automatically, by simply defining the process within which the materials will be used. Reviews are scheduled and flagged automatically, avoiding the danger of holding out-of-date information. The Risk Assessment is available as a database record and is therefore readily available to anyone who needs it, in any location, without having to access a central paper record as is usually the case. Because RisQ is accessed via a web browser, the information is immediately available to everyone without the need to deploy custom software to their individual desktops. Indeed, remote access can be made available to field operatives. For details, visit http://www.qsiuk.com.

Thermo Fisher Scientific Launches Enhanced Informatics Partner Program Extending the benefits and reach of Laboratory Informatics

Thermo Fisher Scientific Inc. has announced the launch of its enhanced partner program. Designed to support the expansion of Thermo Scientific Informatics activity via its partners around the globe, the world class
program will utilize business partners to better meet customer needs in multiple industries. Thermo Scientific's award winning Informatics offerings include laboratory information management systems (LIMS), chromatography data systems (CDS) and spectroscopy software. Building on its already successful partner program, this expansion will enable many new opportunities for partners to provide sales and services for
Thermo Scientific's Informatics solutions. Partners with specific expertise and coverage in key vertical and geographic markets can expand the breadth of their offerings by including informatics in their solution set. Vendors of complementary hardware and software solutions can embed Thermo Scientific Informatics products to extend the value of their solutions. And, as the valuable business information that resides in LIMS becomes increasingly integral to the overall enterprise, integrators will see increasing requirements to deliver integration and interoperability with enterprise level applications such as ERP and other business software. For details, visit http://www.thermo.com/informatics.

LabPas CT Selected by Qualia Clinical Services for Phase I Clinical Trials

Qualia Clinical Services, a division of Holmes Biopharma, has agreed to purchase LabPas CT to automate clinical trials in its recently expanded Phase I facility in Omaha, Nebraska. "Automating our recently expanded Phase I facility with LabPas CT will enable us to provide our Pharma and Biotech sponsors with top quality, highly efficient, state-of-the-art clinical trials," said Azhar Kalim, Vice President and General Manager. Qualia Clinical Services is the sixth highly regarded clinical research organizations this year to select LabPas CT. Others include CEDRA Clinical Research, Acclaim Pharma Research, Advanced Biomedical Research, Arkansas Clinical Research and Nucleus Network. The rapid success of Qualia's Phase I facility, which opened in the fall of 2006, necessitated the recent addition of 10,000 square feet. The clinic now boasts a total of 33,000 square feet, a bed capacity of over 160 beds and more than 120 professional staff. Additionally, administrative, operational and recreational areas were completely redesigned to better serve clients and study participants. Qualia Clinical Services is changing lives for the better by providing its partners in the clinical research industry the full capabilities to complete early and late phase clinical trials. A full service contract research organization, Qualia has state-of-the-art clinical operations in Omaha, Nebraska, Toronto, Canada and Kiev, Ukraine. Green Mountain Logic’s LabPas CT product comprehensively manages Phase I clinical trials, from recruiting through export to EDC. For details, visit http://www.qualiaclinical.com or http://www.labpas.com.

Bruker Daltonics Introduces New Novel Proteomics Capabilities and Solutions

Bruker Daltonics has announced several novel capabilities and solutions for proteomics mass spectrometry, including new Compass 1.3 ion trap software and new ProteinScape 2 software. Compass 1.3 ion trap software now enables Bruker’s high-capacity trap HCTultra PTM Discovery System to become the first commercial mass spectrometer fully equipped with both ETD and PTR (Proton Transfer Reaction). Using a unique and innovative ion optics design and chemistry setup for ETD/PTR allows rapid, routine top-down characterization of large peptides and mid-size proteins in the high-capacity ion trap with superior sensitivity. With its new ProteinScape 2 software, Bruker Daltonics introduces a next-generation bioinformatics platform addressing scientists’ current needs in biomarker profiling, quantification and validation. As a comprehensive solution for qualitative and quantitative LC-MS/MS protein analysis, ProteinScape 2 supports all current label chemistries including multiplexed labels, as well as label-free quantification. For details, visit http://www.bruker.com.

Thermo Fisher Scientific Announces New Software Control for the Accela High Speed LC System Using Atlas CDS

Thermo Fisher Scientific Inc. has announced the new Thermo Scientific Atlas Chromatography Data System (CDS) add-on instrument control software for the Thermo Scientific Accela High Speed LC providing integrated instrument control, digital data acquisition, chromatography data processing and reporting. Atlas CDS provides chromatographers with a client/server chromatography-based software solution available for controlling the Accela LC. The new Atlas Extension Kit integrates full instrument control and chromatography data handling for the Accela high speed pump, autosampler and PDA detector, and is designed to marry the rapid data analysis, processing and reporting of Atlas with the High Speed LC separations of the Accela. The unique Accela High Speed LC with sub 2-micron particle columns can operate at the standard pressures of conventional HPLC to 15,000 psi and separate samples faster, with better resolution and efficiency on the same instrument. Thermo Scientific Atlas CDS provides a highly scalable client/server environment for laboratory LAN and WAN networks in pharmaceutical drug development, discovery, QA/QC laboratories, academia, and the food and beverage industries. Designed as a multi-user, multi-instrument data system, it enables remote network access to any Accela so that its data can be fully collected, secured and protected - enabling organizations to make more informed decisions faster. In addition, Atlas provides seamless integration of Accela results with enterprise wide laboratory informatics management systems applications including the full range of Thermo Scientific LIMS: Darwin, SampleManager, Nautilus and Watson. Atlas software control for the Accela system is available immediately in version 8.2 of Atlas. For details, visit http://www.thermo.com/lc.

Thomson Acquires Bioinformatics Company

Thomson has acquired Prous Science. Thomson provides information management systems for businesses, and the acquisition will allow it to expand its portfolio with Prous's life sciences software. Financial terms of the transaction have not been disclosed. "Prous Science has built a strong global brand on its flagship solutions, which have been built by scientists for scientists,' said Vin Caraher, president and CEO of Thomson Scientific. 'This acquisition really complements our pharma and biotechnology workflow solution offerings." Prous Science's offerings include the Integrity portal that provides information about more than 265,000 compounds and 100,000 patent family records. It is hoped that Thomson will also benefit from Prous Science's links with global medical. For details, visit http://www.prous.com or http://www.thomson.com.

National Instruments Extends LabVIEW Embedded Platform to Support New Analog Devices Blackfin, Freescale ColdFire Processors

National Instruments has announced the extension of the NI LabVIEW 8.5 graphical system design platform to new embedded targets with the release of the NI LabVIEW Embedded Module for ADI Blackfin Processors 2.5 and the LabVIEW Microprocessor SDK (Software Development Kit) 2.5. With a graphical system design approach, engineers and scientists can use LabVIEW to rapidly design and prototype their embedded systems and easily deploy them to targets such as 32-bit processors and FPGAs. The latest versions of the LabVIEW Embedded Module for Blackfin Processors and the LabVIEW Microprocessor SDK expand the available deployment options for engineers and scientists by adding support for new, high-performance convergent multimedia Blackfin processors as well as introducing support for the Freescale ColdFire processor. The software packages also deliver 18 percent increased efficiency in code generation. The LabVIEW Embedded Module for Blackfin Processors seamlessly integrates LabVIEW 8.5 and ADI VisualDSP++ 5.0 to deliver an out-of-the-box embedded programming experience. The combination of the LabVIEW graphical development environment and high-performance, low-power Blackfin processors helps engineers rapidly develop sophisticated embedded systems ranging from cutting-edge medical devices to subsea monitoring systems while optimizing costs and shortening time to market. The latest version of the LabVIEW Embedded Module for Blackfin Processors adds support for the ADSP-BF54X family of processors, which provide on-chip peripheral interfaces for several user interface elements such as a keypad, scroll wheel and touch panel display. The LabVIEW Embedded Module for Blackfin Processors 2.5 further simplifies embedded system development by introducing a drag-and-drop interface to help engineers easily access Blackfin peripherals, significantly decreasing the time required to incorporate I/O into applications. Additionally, the module adds new drivers for digital I/O, counters and timers, interrupts and a real-time clock. With the LabVIEW Microprocessor SDK, engineers can develop and deploy LabVIEW code to any 32-bit embedded processor. Using the latest version of the software package, they now can target the Freescale ColdFire processor with the uClinux embedded operating system in addition to the previously supported processor architectures of ARM7, TI c6000, PowerPC, x86 and XScale. The LabVIEW Microprocessor SDK 2.5 also adds a background TCP/IP debugging capability that makes it easy for engineers to debug their applications while maintaining real-time performance. The LabVIEW Embedded Module for Blackfin Processors and the LabVIEW Microprocessor SDK are part of the LabVIEW embedded platform, a family of National Instruments products that provides domain experts with a complete software programming environment and a range of deployment targets such as custom processors, real-time industrial controllers and FPGAs for the development of embedded systems. For details, visit http://www.ni.com/blackfin.

Invetech Expands its Service Offering into the Drug Discovery Market

Invetech, a worldwide leader in the development of biomedical instruments and automated research & manufacturing processes, has extended its innovative service offering to the drug discovery market. The company's expertise crosses a number of disciplines crucial to the drug discovery process including liquid handling, plate handling, robotics, software interfaces, optics, specialized detection systems, miniaturization and integration. Jari Palander, Vice President of North American Operations at Invetech, comments: "Invetech is capable of handling difficult challenges - our scale, breath of expertise and skills, and diverse project experience enables us to think out-of-the-box and uncover innovative, proprietary solutions and integrate these with our clients' new and existing systems." Invetech's track record builds on thousands of development projects
worldwide. The company has recently demonstrated its expertise with the development of the base technology with complex multi-lane microfluidics on asilicon based fluidics chip. In a matter of months, Invetech designed a
proprietary drug discovery platform on that base technology, integrating commercial autosamplers with complex fluidics and high performance fluorescence cellular imaging. The final system enabled previously unfeasible cellular assays for cell apoptosis and ADME/Tox analysis. In another case, Invetech was asked to develop an in-house high throughput screening platform on behalf of a leading North American company. Working in close collaboration with the client's technology R&D department enabled Invetech to enhance the design of the system and replicate it for supply to global divisions. For details, visit http://www.invetech.us.

Thermo Fisher Scientific Works with Microsoft to Web-Enable its LIMS Solutions

Thermo Fisher Scientific Inc. has announced that it is Web-enabling its LIMS offerings by utilizing Microsoft’s ClickOnce deployment technology to create a solution that combines the rich functionality and performance of the desktop client delivered via the simplicity of a Web interface. A JupiterResearch report titled, “Smart Client Applications: The Best of Both Worlds—The Desktop and the Web” states that “IT decision makers seek software applications that leverage the transport capabilities of the web, but also leverage the power of the desktop for superior usability.” By Web-enabling its LIMS, Thermo Fisher provides customers a hassle–free deployment strategy, as well as easy maintenance and transparent updates from a central point on the network. "With Web-enabled Thermo Scientific LIMS, organizations now have access to a full-featured LIMS with an efficient and cost-effective deployment mechanism,” said Dave Champagne, vice president and general manager of Thermo Fisher Scientific, Informatics. “This announcement underscores our strategic relationship with Microsoft. We are implementing Microsoft technologies, such as the Microsoft .NET Framework 3.0, SQL Server, Office Open XML, Windows Presentation Foundation and Office SharePoint Server to future-proof our customers’ IT investments.” Historically, the deployment of LIMS applications has followed a two-step client-server process: the product is first installed on the central server, and then individually on each of the client workstations. With this new Web deployment functionality, the Thermo Scientific LIMS is installed once onto a central server. A URL is then sent to designated users, enabling them to run the application securely and transparently in a separate “sandbox” on their machines, minimizing its impact on the rest of the system, thus enabling easier validation and mitigating the risk of application conflicts so often associated with client installations. This “zero-touch” process means that IT departments do not need to install these files individually for each user, saving significant time and resources. Global organizations are seeking applications that take advantage of the flexibility of the Web, while still harnessing the full power and rich user experience of desktop clients. Thermo Scientific LIMS enabled by Microsoft’s ClickOnce software has been introduced in response to customer demand, and delivers the core functionality that IT departments require while using fewer computer resources. "Life sciences customers are seeking to take advantage of the Web, but still want the rich functionality of a desktop client,” said Paul Mattes, managing director of Microsoft’s U.S. Health and Life Sciences Group. “Thermo Fisher Scientific’s solution strikes a great balance, by delivering a scalable and secure back-end server, connected to desktop clients via a Web-based interface.” Combining the ease of installation of a Web-based application with the rich functionality of a desktop client, Thermo Scientific LIMS built on the Microsoft platform lowers the cost of ownership because the application is managed and deployed from one central point. For details, visit http://www.thermo.com/informatics.

Labtronics Partners with PEC & Technologies for Distribution of LimsLink to Forensic Laboratories

Labtronics Inc., provider of laboratory data integration and management solutions, and PEC & Technologies Inc., providers of b.a.r.d. LIMS for forensic sciences, have announce a new partnership agreement that will make LimsLink the instrument interfacing solution of choice for b.a.r.d. LIMS. b.a.r.d LIMS is a global laboratory information management system (LIMS) that offers all the advantages of a LIMS while integrating the management of the evidence in a manner that fits precisely with the needs of forensic laboratories. b.a.r.d LIMS manages all analysis requests made to the forensic laboratory. It includes functions that allow management of the exhibits, analyses, results, expertise reports, analytical instruments, qualifications of laboratory's personnel, quality controls, etc. b.a.r.d LIMS enables a laboratory to be compliant with ASCLD/LAB and ISO Guide 25 Standards. LimsLink is a fully configurable software solution for creating instrument to LIMS interfaces that deliver the right level of automation to suit the instrument, the laboratory workflow and the analysts.
Using LimsLink to automate the transfer of data between laboratory instruments and b.a.r.d. LIMS will improve laboratory performance by reducing the cost of sample data management, reducing analysts’ workload and delivering sample results to LIMS faster. For details, visit http://www.labtronics.com/ll.htm.

ClinPhone Announces Significant New Contract with Bayer Yakuhin Ltd, Japan

ClinPhone, a global leader in clinical technology solutions, has been appointed as the preferred supplier of randomization and trial supply management services by the Japanese affiliate of leading pharmaceutical company, Bayer. ClinPhone won this major new contract in Japan with Bayer Yakuhin Ltd, shortly after opening its first Asia Pacific office in Melbourne, Australia. The contract award was confirmed in February 2007 and the project went live successfully and on schedule. Under the terms of the agreement ClinPhone will supply Bayer Yakuhin Ltd with services powered by Interactive Voice Response (IVR) technology in a key Phase III study taking place in Japan. ClinPhone technology has set the standard for clinical trial management systems built on experience across thousands of Phase II-IV clinical trials. This contract with Bayer Yakuhin Ltd represents another example of a leading Japanese pharmaceutical company taking advantage of ClinPhone’s industry leading IVR clinical technology to manage the randomization and supply chain logistics involved in delivering a highly complex clinical trial. ClinPhone delivers technology solutions for several major Japanese pharmaceutical clients globally and this project represents a major expansion into the Japanese market itself. In addition to Japanese, ClinPhone has experience of providing its applications to leading global pharmaceutical and biotechnology clients in over 70 languages and dialects worldwide. As the industry’s leading Clinical Technology Organization, ClinPhone has accumulated more than 15 years’ experience in providing telephone and web-based trial management solutions in over 2000 clinical studies across more than 80 countries. For details, visit http://www.clinphone.com.

Multinational Biopharmaceutical Company Licenses LabVantage's Sapphire to Support Its Core Biomaterial Research for Cancer and Immunological Therapies

LabVantage has announced that a global biopharmaceutical company has licensed LabVantage's Sapphire LIMS to automate their research process and establish an enterprise-wide knowledgebase of research data. The
global biopharmaceutical company concentrates on the discovery, development and commercialization of
groundbreaking therapies designed to treat cancer and immunological diseases. They have successfully
marketed a number of commercial products as well as cellular and tissue therapeutics. The division deploying Sapphire is responsible for supplying research expertise to multiple product development teams and pioneered the recovery of stem cells from human placental tissue following the completion of a full-term, successful pregnancy. Prior to deploying Sapphire, they had to manually intercede to facilitate the efficient entry and routing of work requests for approval. They plan to use Sapphire's automated request approval/rejection routing functionality, along with a number of flexible workflow capabilities, to eliminate the manual intervention and streamline their workflow process, expediting the initiation and execution of their work order requests. Further, they intend to store test results derived from these work requests in Sapphire, providing a central knowledge repository accessible enterprise-wide through a zero footprint web browser. "We are very excited about this global biopharmaceutical company's decision to deploy Sapphire and we are thrilled with the rapid pace of the project from kick-off to full functionality solution acceptance in less than six months," stated Jim Aurelio, CEO & President of LabVantage, "As the complexity of mission-critical research intensifies, Sapphire continues to support research & discovery organizations with innovative research management solutions that enable them to convert their research into commercialized products and therapeutics." For details, visit http://www.labvantage.com.

National Instruments Introduces LabVIEW 8.5 Real-Time

National Instruments' LabVIEW 8.5 Real-Time introduces leading-edge technology enhancements to support multicore processors through symmetric multiprocessing (SMP). Using LabVIEW Real-Time, users can assign tasks (or threads) with the LabVIEW timed loop to specific cores for tighter control of their application. The LabVIEW Execution Trace Toolkit Version 2.0 focuses on performance and environment response time. Now users can visually analyze threads on multiple cores simultaneously. Also, LabVIEW Real-Time incorporates many customer-requested features, such as support for the Reliance file system for greater reliability, a CPU monitor utility, and new memory management functions. For detailss and to view a webcast, visit http://www.ni.com.

ARTEL Extreme Pipetting Expedition to Visit Death Valley to Test Impact of Dry Heat on Laboratory Data

ARTEL has announced that Death Valley National Park will be the site of Mission #3 of the Extreme Pipetting Expedition. At Death Valley, located in the desert spanning Nevada and California, ARTEL will test how dry and hot environmental conditions alter pipetted volumes. Dry heat was chosen as the scientific focus of Mission #3 because many laboratory technicians commonly encounter this condition in their work environments. For example, laboratories using analytical instruments, ovens, incubators, freezers, and other devices using high power or open flames are prone to heat and low humidity. Dry heat can also be contributed by heating and air-conditioning systems not equipped with humidifiers. To ensure pipetting accuracy and precision and strengthen data integrity, it is essential that laboratory scientists understand and compensate for this source of error. ARTEL will release the results from Mission #3 at the Association for Molecular Pathology (AMP) 2007 Annual Meeting and Exhibits (booth #54), November 7-10, 2007, at the Hyatt Regency Century Plaza Hotel in Los Angeles, CA. A 3.3 million acre desert, Death Valley was selected as the site for Mission #3 because it is iconic for its hot and dry climate. Surrounded by mountains, the valley captures and retains extreme amounts of heat to create one of the hottest environments on earth, commonly exceeding 49oC (120oF). Death Valley is also the driest locale in the United States, receiving fewer than two inches of rain annually. The Extreme Pipetting Expedition is a multi-phase, year-long scientific study to illustrate the impact of laboratory environmental conditions on pipetting performance and data integrity. Previous missions explored how barometric pressure and how pipetting warm and cold liquids affect data integrity. For details, visit http://www.artel-usa.com/extreme.

Labtronics Releases LimsLink v4.1

Labtronics has announced that the latest release of LimsLink v4.1 provides enhancements to further assist regulated organizations with deployment of LimsLink for large numbers of users, across different geographical locations, while still maintaining compliance with data integrity regulations such as 21 CFR Part 11. Enhancements include: (1) new security and audit trail systems that allow for the centralization of security and audit trail functions in an enterprise network deployment with options to install them with the LimsLink smart client or remotely on a separate server; (2) new workstation IDs that can be assigned to each instance of LimsLink, simplifying use in a Citrix environment; (3) the logon dialog and statusbar now displays the identification of the server name, making it easier to identify the system that the user is connected to in a multi-system environment; (4) control over cell editing rights within LimsLink have been changed from password level security to security assignments based on users and groups; and (5) 4.1 incorporates field fixes previously provided under LimsLink v4.0. For details, visit http://www.labtronics.com/ll.htm.

Shell Global Solutions Utilizes Thermo Fisher Scientific iCAP 6500 Spectrometer for Testing Racing Cars at Le Mans 2007

Thermo Fisher Scientific Inc. has announced that its iCAP 6500 spectrometer was employed by Shell Global Solutions in the mobile laboratory at the 24 hour Le Mans race 2007. The Thermo Scientific iCAP 6500 spectrometer is part of the award-winning Thermo Scientific iCAP 6000 series of ICP emission spectrometers. Designed for a wide range of industries and specifically suited to the needs of general and elemental analysis laboratories in the petrochemical industry, the iCAP 6500 features a unique radial plasma, ideal for testing the condition of car engine oils, lubricants and hydraulic fluids. Shell Global Solutions ran tests in the mobile laboratory for their technology partner Audi Sport, the race winners, as well as fuel quality monitoring as exclusive fuel supplier to the ACO for all competitors. The Thermo Scientific iCAP 6500 was installed in a fleet truck and all competing teams were invited to supply fuel samples out of the pits for monitoring fuel quality to avoid potential engine reliability issues. Le Mans race regulations state that an engine cannot be changed during the 24 hour endurance race, however engine parts may be changed or fixed. This service, especially for lubricants, therefore offered extended benefits as it enables a racing team to change engine parts as required, following the results of the testing with the iCAP. For details,visit http://www.thermo.com/elemental.

PerkinElmer Introduces New Gas Chromatograph

PerkinElmer Life and Analytical Sciences, a global leader in application-focused measurement and analysis solutions, has announced the introduction of the Clarus 400 gas chromatograph (GC), designed to meet the needs of industrial/analytical laboratories in price-sensitive environments and academic laboratories globally.
“Increasingly, we are tailoring our offerings to meet the skill level, analytical and productivity demands of the user. We developed the Clarus 400 GC in response to the strong demand for reliable, world-class GC technology in budget-conscious laboratories without sacrificing performance,” said Eric Ziegler, Vice President of Chromatography for PerkinElmer Life and Analytical Sciences. “For example, the Clarus 400 GC’s single-channel and dual-channel capability with choice of injectors and detectors offers the flexibility and performance to meet diverse applications needs.” The Clarus 400 GC offers an optional autosampler for increased productivity and has a number of features to support laboratories in global markets including a choice of keypad user interfaces in five languages. It is designed for an easy installation supported by localized documentation. Also, as with all other GCs in the Clarus family, the Clarus 400 GC can be coupled with PerkinElmer’s TurboMatrix™ Headspace Samplers and Thermal Desorbers for added application capabilities.
The Clarus 400 GC is an integral part of PerkinElmer’s Clarus family of GC instrumentation for customers in the environmental, food and beverage, forensics, petrochemical, materials testing and academic markets. In addition, PerkinElmer is the only gas chromatography supplier who develops, manufactures, supports and services every product it offers to provide a truly integrated system. This means one expert supplier – with best-in-class instruments and a world-class service and support organization – can address all of your applications and troubleshooting needs, from sample handling to data handling. For details, visit http://www.perkinelmer.com/Clarus400GC.

Conner Announces Plan to Improve Quality Compliance of Genetically Engineered Products

Acting Agriculture Secretary Chuck Conner has announced a new program to help universities, small businesses and large companies develop sound management practices to enhance compliance with regulatory requirements for field trials and movements of genetically engineered (GE) organisms. The new Biotechnology Quality Management System, a voluntary compliance assistance program, is scheduled for initial implementation in spring 2008. "Biotechnology is a key component of our growing agricultural economy," said Conner. "USDA's program will help the biotechnology sector become better stewards by focusing on the implementation of best management practices so that problems can be prevented." USDA's biotechnology initiative complements a program called, "Excellence Through Stewardship," which is already underway in the biotechnology industry. While industry's program is focused on quality management to ensure product integrity of biotech-derived plant products throughout the product life cycle, USDA will emphasize the quality of the process for safely introducing these GE organisms in compliance with federal regulations. The Biotechnology Quality Management System was developed to be as inclusive as possible so that a broad array of participants could participate. It will consist of two program levels, based on domestically and internationally recognized quality management systems. Specifically,
1) Level-A program: This program will be designed for participants that do not have formal quality management systems in place. It will help them develop good management procedures and will be geared toward small businesses and universities.
2) Level-B program: Companies and researchers that have formal management systems in place may choose to participate in the Level-B program. This program is intended for those participants that grow GE plants at multiple sites, often through the use of cooperators, and will include training guidelines and documentation procedures to ensure accountability at all levels by all involved parties.
USDA's Animal and Plant Health Inspections Service (APHIS) intends to oversee the Biotechnology Quality Management System program in partnership with USDA's Agricultural Marketing Service (AMS), which will manage the audit component of the program and accredit third party auditors. Audits will verify that participants have procedures in place, and that they are performed correctly to meet the regulatory requirements for any given GE field trial or movement. As part of the program's emphasis on preventive measures, participants will be encouraged to correct deficiencies discovered in an audit before compliance problems develop. The Biotechnology Quality Management System and its associated audits will complement, not replace, APHIS' current regulatory compliance and inspection process by focusing on planning and good management practices that can improve a participant's ability to meet regulatory requirements. The current inspection program will continue to cover specific permits and notifications to ensure compliance with regulations. APHIS, in partnership with AMS, will implement the voluntary system through an agency notice and participation in the program will not be a regulatory requirement. APHIS also will work proactively to provide outreach and guidance to those companies and researchers that choose to participate and develop these quality management programs. Currently there are several audit-based, quality verification systems in operation throughout USDA's marketing and regulatory programs mission area, such as AMS' Process Verified Programs. APHIS regulates the confined field release, interstate movement and importation of GE organisms. APHIS currently ensures compliance with regulations through inspections conducted at critical stages, consistent and appropriate enforcement actions and comprehensive record keeping and reporting requirements. Quality management systems are intended to improve regulatory compliance by fostering a company's commitment to sound controls, quality management practices and effective compliance with federal regulatory requirements. For details, visit http://www.aphis.usda.gov.

Thermo Fisher Scientific Appointed as Corporate Standard LIMS Supplier for South African Utilities Organization

Thermo Fisher Scientific Inc. has announced that ESKOM, the largest electricity supply company in Southern Africa, signed a contract in June 2007 to rollout Thermo Scientific SampleManager LIMS to its thirty four laboratories. The project will be delivered via Thermo Fisher’s partner in South Africa, LimsTricS. As the corporate standard at ESKOM, the Thermo Scientific SampleManager system will be used to track, store, manage, report and share analytical data enterprise-wide. The standardization project is focused on saving costs as well as improving decision making through the more efficient use of data. In reaching the decision to rollout SampleManager LIMS, ESKOM went through a rigorous process of evaluating different LIMS products, including three pilot installations and the implementation of specific laboratory workflows. This enabled the ESKOM project team to do an in-depth evaluation of the short listed LIMS products and choose (or decided on) the best solution that met their needs. SampleManager LIMS was selected by ESKOM for rollout to thirty four laboratories sited across South Africa based on industry expertise and the suitability of SampleManager for the application. LimsTricS, the local Thermo Fisher Scientific implementation partner for South Africa will implement the system at ESKOM. LimsTricS has extensive experience in implementing SampleManager LIMS and has represented Thermo Scientific LIMS products in Southern Africa since 1998. For details, visit http://www.thermo.com/informatics.

QSI Establishes New Division in France

Quality Systems International has established a new division in France to enhance supply and support of its market-leading quality control software products. QSI’s WinLIMS is a feature-rich “Out of the Box” LIMS solution with over 10 years of successful installations world wide, whilst related QSI products address quality issues such as Risk Assessment, and Document Control. Announcing the new division, QSI UK Managing Director Clive Collier said “We wanted our customers in France to enjoy even better access to the service and support which has made QSI the preferred LIMS supplier for hundreds of users world wide – our services have been shown by the international Forrester LIMS Watch Survey to be of the very highest standard. QSI is an independent company, and we maintain our position and competitive edge by providing top quality products and outstanding service. We are pleased to launch WinLIMS Rental for the French market." QSI’s new facility is based at QSI France, Immeuble les Maradas, 1 Boulevard de l'Oise, 95030 Cergy Pontoise, CEDEX. For details, visit http://www.qsifr.com.

Spellex Releases Spellex Biotech V.2007, the Newest Upgrade of the World’s First Bioscience Spell Checking Software

Spellex Corporation has announced the new release of the 2007 version of their popular bioscience spelling software for Microsoft and other programs. The new release includes more than 200,000 specialty words from the bioscience industry and new spelling engine enhancements. Spellex Biotech is a comprehensive spelling dictionary reference that adds more than 200,000 bioscience terms to the user’s spell checker for specialties ranging from Agronomy to Zygote research. Spellex Biotech covers more than 70 different bioscience fields including agronomy, biochemistry, bioinformatics, biomedical engineering, biophysics, ecology, molecular and genetic biology, microbiology, organic chemistry, taxonomy, toxicology, and pharmacology, to name only a few. Spellex Biotech includes thousands of abbreviations and acronyms encompassing scientific product names and devices, as well as medically and biotechnologically relevant organisms. By adding Spellex Biotech to a Microsoft or WordPerfect program, the spell checker will provide correct spelling choices for incorrectly spelled bioscience terminology. The spell checker also allows users to look up unsure spelling of bioscience words by phonetic or typographical search without leaving their document. The regular Microsoft or WordPerfect spelling dictionary and the Spellex dictionary are spell checked simultaneously with one mouse click. Spellex Corporation has added more than 20 Customer-Driven enhancements to their Spellex Biotech 2007 spell check program, including upgrades and updates to the biotech dictionary, spelling engine, registration program, and installation program. Spellex dictionaries are compatible with Microsoft, most Windows programs, developer tools, custom applications, Web browsers, and are available in US English or UK English. For details, visit http://www.spellex.com/products/biotech.htm.

Virginia Bioinformatics Institute Implements Metabolomics Software from ACD/Labs to Tackle Biomedical and Agricultural Research.

Researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech are examining ways in which metabolomics can be applied to the study of systems biology. Recently, they invested in new technology, ACD/IntelliXtract, to further enhance their ability to handle the data obtained by liquid chromatography/mass spectrometry (LC/MS). Metabolomics involves the systematic study of the metabolic processes of living cells and requires the high-throughput analysis of a large number of small-molecule cellular metabolites. While current instrument technology enables samples to be analyzed more and more quickly, the resulting avalanche of data must then be managed—often an overwhelming task. ACD/IntelliXtract quickly and accurately extracts all chromatographic components, assigning adducts and interpreting mass spectra for each component. Components of interest can then be labeled and isolated from other components for identification, helping researchers to gain a quicker understanding of their results. Moreover, this process can be carried out as part of manual data interpretation for a few samples, or can be automated for large numbers of samples. "We were looking for software that could help alleviate the pressure of data interpretation we were experiencing. There is an inevitable backlog of information that occurs with high-throughput analysis and ACD/IntelliXtract is able to automate some of that work," said Dr. Vladimir Shulaev, Associate Professor at VBI and the head of the Biochemical Profiling Research Group. "Having already used ACD/MS Manager extensively, we were familiar with ACD/Labs software and their customer service, and confident about the quality of the results IntelliXtract would generate." One application—especially useful to VBI's metabolomics studies—uses ACD/IntelliXtract to assist with related fragment screening, taking advantage of the fact that many intermediates in a metabolic pathway have similar structures. Exploiting this knowledge in identifying and elucidating metabolites seems intuitive; however, in practice, organizing the data and visualizing relationships is much more difficult. With the help of ACD/IntelliXtract, LC/MS data is automatically analyzed and organized, presenting the relevant data for related metabolites in a clear and concise report. For details, visit http://www.acdlabs.com.

Labtronics' NAP Version 4.4 Released with New Enhancements for Significant Timesavings

Labtronics has announced the release of the NAP version 4.4, analog data acquisition and peak analysis system for Windows 2000, XP Professional or Vista Business operating systems. Major enhancements to the software include the ability to append new samples to previously run data files, create new data files using a previously created calibration curves, and re-define the active and archive data directories to anywhere on the local PC or LAN. The new features are expected to save labs significant amounts of time when rush samples come in for analysis or when setting up new sample trays that would have previously required standards that have not yet expired to be inserted into every run. The NAP system includes software and a 24-bit external USB analog-to-digital interface box to connect up to 6 detectors. Additional options are available to control samplers and pumps. Each detector setup in the software can have a user-defined maximum scale between 0 to 5 volts on an individual channel basis. At run-time, data points are drawn on the chart as they are collected for each channel. The NAP software adds the peak positions based on each channels method criteria and determines the concentration for each sample against its standard calibration curve. Throughout the run, NAP can automatically correct for baseline and gain drift changes against the calibration curve to automatically adjust each sample's calculated concentration. For details, visit http://www.labtronics.com/nap.htm.

STARLIMS to be Implemented by Schiff Nutrition International

STARLIMS Technologies' web-based LIMS is to be implemented by Schiff Nutrition International. Schiff develops vitamin and nutritional supplements in the United States and throughout the world. STARLIMS was chosen partly for its experience in the pharmaceutical and food and beverage industries. It is also easily customizable.
Abel Sekepyan, the LIMS administrator at Schiff, said: ‘We plan to make use of existing Starlims tools, configuring them to match our own business and laboratory practices. We look forward to further automating the flow of data at Schiff, making our environment as paperless as possible.’ STARLIMS V10 will interface with a wide range of instruments, helping manage sample login, chain of custody, test scheduling, results entry, training records, laboratory consumables inventories, stability studies and other processes. The decision will also provide more stringent quality and traceability, helping Schiff to comply with the US Food and Drug Administration’s new regulations for manufacturers of vitamins, herbal pills and other dietary supplements, which will go into effect August 24, 2007. For details, visit http://www.STARLIMS.com.

QSI and Brady Corporation Link the Sample to the Data

A new strategic business partnership between QSI, supplier of WinLIMS, and Brady Corporation, world leader in labelling technology, can now deliver unique solutions for sample labelling and laboratory information management. Durable, legible labelling is essential to ensure the integrity of sample identification with laboratory data. The QSI WinLIMS Rental package has all the functionality to meet individual user requirements - robust sample tracking, GLP compliance, accurate reporting – but these functions require unequivocal, reliable sample identification to realise their full potential. Brady’s labelling products provide secure, permanent labelling solutions for the most demanding environments met in the laboratory – extreme temperatures, solvents, chemicals – that are reliably readable by user and machine alike, and can contain far more information about the sample than any hand-written label. A range of label generation software, printers and readers is available to produce labels for use on most commonly used laboratory consumables – microscope slides, well plates, vials, “straws”, centrifuge tubes, flasks and many others. In combination, these two technologies offer new and unique possibilities to exploit the full potential of Laboratory Information Management, and the new partnership will ensure seamless integration between the laboratory’s sample ID and labelling system and WinLIMS. For details, visit http://www.lims-software.co.uk.

ClinPhone and LabPas CT Agree to Interface

ClinPhone, a leading specialist provider of technology solutions to the clinical trials industry, has agreed to develop an interface between its EDC product and LabPas CT, a leading software solution for Phase I clinical trials, according to Green Mountain Logic, developer of LabPas CT. An interface between ClinPhone EDC (formerly known as DataLabs Clinical) and LabPas CT will reduce the cost and duration of Phase I clinical trials, while also improving the accuracy, integrity and consistency of the data collected. In addition, both ClinPhone EDC and LabPas CT are highly regarded in the industry for their ease of use. John Rosenblum, Green Mountain Logic CEO stated, “I am delighted to announce this agreement between ClinPhone and Green Mountain Logic, two leaders in their respective fields with products designed for intuitive use.” For details, visit http://www.clinphone.com or http://www.labpas.com.

Spellex Releases Spellex Biotech v.2007 Bioscience Spell Checking Software

Spellex Corporation has released the 2007 version of their bioscience spelling software for Microsoft and other programs. The new release includes more than 200,000 specialty words from the bioscience industry and new spelling engine enhancements. The Spellex Biotech spelling dictionary allows users to save time and increase their accuracy. By adding Spellex Biotech to Microsoft or WordPerfect programs, the spell checker will provide correct spelling choices for incorrectly spelled bioscience terminology. The spell checker also allows users to look up unsure spelling of bioscience words by phonetic or typographical search without leaving their document. The regular Microsoft or WordPerfect spelling dictionary and the Spellex dictionary are spell checked simultaneously with one mouse click. Spellex Corporation has added more than 20 Customer-Driven enhancements to their Spellex Biotech 2007 spell check program, including upgrades and updates to the biotech dictionary, spelling engine, registration program, and installation program. Spellex Biotech is a comprehensive spelling dictionary reference that adds more than 200,000 bioscience terms to the user’s spell checker for specialties ranging from Agronomy to Zygote research. Spellex Biotech covers more than 70 different bioscience fields including agronomy, biochemistry, bioinformatics, biomedical engineering, biophysics, ecology, molecular and genetic biology, microbiology, organic chemistry, taxonomy, toxicology, and pharmacology, to name only a few. Spellex Biotech includes thousands of abbreviations and acronyms encompassing scientific product names and devices, as well as medically and biotechnologically relevant organisms. Users can also correctly spell newly introduced bioscience terminology by subscribing to the Spell-X-BioPlus software subscription service. This quarterly software subscription service updates the Spellex dictionaries with new biotechnology terms, new pharmaceutical terms, and more. Spellex dictionaries are compatible with Microsoft, most Windows programs, developer tools, custom applications, Web browsers, and are available in US English or UK English. For details, visit http://www.spellex.com/products/biotech.htm.

ALA Expands Innovation AveNEW Program Globally Partnering with BioAlps Switzerland

The Association for Laboratory Automation (ALA) has announced that an agreement has been reached with BioAlps – Lake Geneva BioCluster, Switzerland, uniting the two scientific organizations to further expand ALA’s Innovation AveNEW program. Kicking off the calendar year, LabAutomation2008 is the platform event for established companies launching new products and services. Innovation AveNEW is an in-kind, cost-sensitive program affording emerging, start-up companies the opportunity to actively engage and participate in a world-class event which helps to grow and scale their business as well as directly connects them as an exhibitor with purchasing influencers and decision-makers from more than 40 countries. According to ALA President Reinhold Schäfer, strategically aligning with BioAlps helps both organizations deliver on their educational and business objectives. "Our mission for Innovation AveNEW is simple,” said Schäfer. “We want to offer start-up, entrepreneurial companies from around the world in the laboratory automation and technology field a venue for positive, collaborative interaction and exposure for their product and/or service concept. Working with BioAlps, we will now be better able to communicate and connect with young companies in Europe.” There will be only eight start-up companies selected to participate in Innovation AveNew at LabAutomation2008, inclusive of the BioAlp’s Exhibitor Delegate. BioAlps is currently developing its scientific review panel to select the BioAlp’s Exhibitor Delegate at LabAutomation2008. BioAlps General Secretary Raphael Conz believes the partnership with ALA is an excellent opportunity to help bring exposure to Switzerland’s burgeoning biotechnology industry. “We believe participating together with ALA in such a high-caliber program for young, start-up companies is critical for business development both here in Switzerland and abroad. With the support and involvement of our two organizations, we anticipate this program will be an immediate success.” For details, visit http://www.labautomation.org or http://www.bioalps.org.

Bruker BioSciences Reports Strong Revenue and Net Income Growth in the Second Quarter of 2007

Bruker BioSciences Corporation has reported financial results for the three and six months ended June 30, 2007.
For the second quarter of 2007, revenue increased by 21% to $121.7 million, compared to revenue of $100.5 million in the second quarter of 2006. Excluding the effects of foreign currency translation, second quarter 2007 revenue increased by 17% year-over-year. Net income in the second quarter of 2007 was $5.0 million, or $0.05 per diluted share, compared to net income of $2.5 million, or $0.02 per diluted share, in the second quarter of 2006. For the six months ended June 30, 2007, revenue increased by 19% to $232.2 million, compared to revenue of $195.3 million during the six months ended June 30, 2006. Excluding the effects of foreign currency translation, revenue for the six months ended June 30, 2007 increased by 14% year-over-year. Net income during the six months ended June 30, 2007 was $8.8 million, or $0.08 per diluted share, compared to net income of $5.8 million, or $0.06 per diluted share, during the six months ended June 30, 2006. "The combination of our innovative products and solutions and favorable market dynamics enabled us to deliver solid increases in
revenue and net income," said Frank Laukien, President and Chief Executive Officer, when commenting on the quarter. "We are very pleased with our second quarter 2007 year-over-year currency-adjusted revenue growth rate of 17%, which included an accelerating organic growth rate of 12% year-over-year. Moreover, new product introductions from both our core businesses and recent acquisitions have further strengthened our position as a leader in high-performance life-science and analytical systems, and have contributed to our very healthy
backlog, which positions us well for the second half of 2007." For details, visit http://www.bruker-biosciences.com.

STARLIMS Receives ‘Designed for EMC Documentum’ Accreditation

STARLIMS Technologies Ltd., a leading global provider of LIMS, has announced that its STARLIMS Version 10 software has received the “Designed for EMC Documentum” accreditation, a mark of quality and value that customers depend on in enterprise applications. The “Designed for EMC Documentum” accreditation demonstrates that STARLIMS Version 10 has successfully met a comprehensive set of criteria for good design, development and integration with the EMC Documentum platform. STARLIMS Technologies Ltd. develops and markets a commercial off-the-shelf LIMS that has been deployed in hundreds of organizations around the world. Leveraging the EMC Documentum enterprise content management (ECM) platform, STARLIMS Version 10 users can now manage data from LIMS and other enterprise systems from within a single repository. STARLIMS Version 10 received design accreditation by meeting high standards for application design, development, configuration, installation processes and overall quality. As a member of the Designed for EMC program, STARLIMS Technologies Ltd. received specialized design consultation and guidance, along with access to dedicated EMC content management technical resources. The company will also be able to include specialized “Designed for EMC Documentum” logos on packaging, marketing collateral, and other promotional materials pertaining to their accredited offering, signifying to customers that the STARLIMS Version 10 software meets high standards for architectural compliance with the Documentum architecture and leverages development best practices. For details, visit http://www.emc.com/applicationportfolio or http://www.STARLIMS.com.

Leading Nutritional Supplement Manufacturer Selects STARLIMS

STARLIMS Technologies Ltd., a leading global vendor of LIMS, has announced that its entirely web-based LIMS will be implemented by Schiff Nutrition International, Inc. Founded 70 years ago and based in Salt Lake City, Schiff develops, manufactures, markets and sells branded and private label vitamins and nutritional supplements in the United States and throughout the world. "We selected STARLIMS partly because of their extensive expertise in the pharmaceutical, nutraceutical and food & beverage industries; and partly due to the technologically advanced web-based software they offer,” said Abel Sekepyan, the LIMS administrator at Schiff. “We plan to make use of existing STARLIMS tools, configuring them to match our own business and laboratory practices. We look forward to further automating the flow of data at Schiff, making our environment as paperless as possible." "We are delighted to work with Schiff in this wide-ranging project, which will improve automation and help ensure regulatory compliance throughout the Schiff laboratory infrastructure,” said Jeff Ferguson, Chief Operating Officer at STARLIMS. According to Ferguson, STARLIMS V10 will interface with a wide range of instruments, helping manage sample login, chain of custody, test scheduling, results entry, training records, laboratory consumables inventories, stability studies and other processes. "There is a marked trend towards more and more stringent regulation in the nutraceutical manufacturing, as in other industries,” added Ferguson. He cited the U.S. Food and Drug Administration’s new regulations for manufacturers of vitamins, herbal pills and other dietary supplements, which will go into effect August 24, 2007. "While Schiff already has stringent quality control of raw materials and all ingredients, other companies in this industry may need to enforce tighter quality control standards as a result of new regulations,” he added. “STARLIMS is ideal for such requirements. It is easily deployed in distributed organizations, vastly facilitating testing, traceability and quality control of raw materials that are sourced on a global basis." For details, visit http://www.SchiffNutrition.com or http://www.STARLIMS.com.

etrials EDC to Interface with Green Mountain Logic's LabPas CT LIMS

An agreement to create an interface between etrials' Electronic Data Capture (EDC) and LabPas CT, a leading Phase I automation software developed by Green Mountain Logic (GML), has been announced by the two companies. The interface provides a complete end-to-end solution for Phase I clinical research and shortens overall trial times while also improving data quality. LabPas CT , a full enterprise solution for the conduct of Phase I clinical trials, will automate key clinical trial data collection, make trial data available in real-time and electronically export validated data to etrials' EDC. etrials' EDC will provide a web-based, globally-proven solution for collecting, managing and analyzing real-time clinical trial information. "etrials' partnership with GML is a great example of our joint commitment to helping clients' accelerate their time-to-market," Chip Jennings, president and CEO of etrials. "The integration of etrials EDC and LabPas CT demonstrates our companies' deep understanding of our clients' real-world challenges. The level of automation this technology interface provides can go a long way to streamlining Phase I clinical trials." For details, visit http://www.labpas.com.

ChemSW Releases New Industry White Paper on How to Survive a Chemical Management Audit

ChemSW, Inc. has announced the release their fourth Best Practices industry white paper, this one detailing best practices that can be leveraged to survive a chemical management audit. ChemSW’s latest white paper examines the challenges inherent in chemical management audits and presents Best Practices solutions to assist chemists in understanding and addressing the myriad chemical inventory management requirements with which they must comply. "Every year, many organizations fail to pass audits of their workplace chemicals,” explains ChemSW Vice President and white paper author Pat Spink. “That’s because those chemicals and related supplies are not managed and controlled in a safe manner in accordance with regulations. One of the main causes for the continuing chemical safety deficiencies in the workplace that drive audit failure is the large number of requirements that govern chemical-related work. This white paper helps point out the areas where deficiencies most often occur and provides pointers on how to avoid audit noncompliance.” Numerous local, state and federal requirements have been promulgated to protect workers, equipment, facilities and the environment from the hazards associated with chemicals. Because such requirements can number in the thousands, simply identifying all of the applicable chemical safety-related requirements that govern any particular work activity with chemicals can be a monumental task. In addition, many of these requirements approach chemical safety from different perspectives, contain overlapping provisions, are sometimes contradictory, and often confusing. "From lubricants to solvents, from flammable materials to corrosives,” adds Spink, “many organizations today handle and store a number of different chemicals that must be managed safely. It’s not enough to ensure that you know where chemicals are, provide training and information about correct handling procedures, and ensure that chemicals are stored and disposed appropriately. There are many rules and regulations to ensure that these minimums take place. Rather, because of all these requirements – some of which conflict – it is extremely important to ensure that your organization is able to pass chemical management audits to prove that your system works both well and safely.” The penalties for failing EPA and OSHA audits related to chemical management on site can be severe. A Best Practices approach can help ensure that the chemical management program that has been implemented works and that the related audits are successful. Entitled “How to Survive a Chemical Management Audit,” the white paper examines how to leverage industry best practices for chemical inventory safety integrity, as well as how to gain control of chemical inventory through the implementation of a chemical inventory system that addresses regulations and dovetails with the organization’s SOPs. A series of best practices activity-based checklists that govern chemical-related work activities -- with overlap and duplication of requirements removed -- have been developed to assist in chemical management audits. The Best Practices components of an end-to-end Chemical Inventory System (CIS) for establishing and maintaining information about the chemical safety and quality data are also explored.
This in-depth white paper is free and available for download from the ChemSW web site at http://www.ChemSW.com/audit.htm.

What's New: September to October 2007 The following is a wrap-up of news of interest during the months of September to October 2007

What's New: September to October 2007
The following is a wrap-up of news of interest during the months of September to October 2007